Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...
Encouraging trial results from Novo Nordisk show that a new combination therapy in development could help people lower their A1C and weight dramatically. With the...
Approximately 17% of people with diabetes have diabetic cardiomyopathy, a dangerous complication that can lead to heart failure. This clinical trial is focused on...
In the search for new and innovative ways to treat type 1 diabetes, researchers have looked to develop therapies that protect or improve the body’s ability to produce...
Vertex Pharmaceuticals announced its intention to acquire the biotechnology company ViaCyte for $320 million in cash, merging two leaders in beta cell replacement...
Researchers are dedicated to developing new mealtime insulins that can help improve glucose management and prevent highs and lows. Exciting new concentrated, ultra-rapid...
See if you are eligible to participate in this study looking at whether the One Touch Solutions platform and its associated partner programs can help people better...
While African Americans, Hispanic/Latino Americans, and Indigenous people can be nearly twice as likely to have diabetes as white Americans, these populations are less...
Positive results from a study of Weight Watchers’ diabetes-tailored program shows reductions in weight, A1C, diabetes distress. Read on to learn more.
Are you an adult with type 2 diabetes who is interested in trying oral insulin? If so, see if you’re eligible for this clinical trial studying how an oral insulin pill...
For many years, a cure for type 1 diabetes has only been a pipe dream for the millions of people living with type 1 diabetes. New data from Vertex Pharmaceuticals on the...
Dr. Ania Jastreboff, of the Yale University School of Medicine, and colleagues presented new data at the ADA 82nd Scientific Sessions in New Orleans, Louisiana, on the...
Learn about a clinical trial designed to study the long-term effects of the GLP-1 receptor agonist semaglutide on eye health and how to enroll if you are eligible.
In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...
Learn more about how you can participate in this clinical trial from Novo Nordisk, testing whether a new once-weekly insulin injection, when combined with semaglutide,...
The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...
Fractyl Health has developed a new technology called duodenal mucosal resurfacing, which can "reset" your gut, leading to improvements in glucose levels and weight and a...
Early trial results found that SGLT-2 inhibitor Jardiance is highly effective at preventing and treating kidney disease in people with or without type 2 diabetes.
Vabysmo, a new drug manufactured by Roche, was recently approved by the FDA to treat two common eye diseases. Find out more about this medication and how it might help...
Participating in clinical trials are a way for people with diabetes to be directly involved in the evolution of diabetes care. Julie Heverly shares her experience being...

Pages